Allogene Therapeutics (ALLO.US) Latest Stock News - Major News Analysis

Event Tracking

Nov7

Oppenheimer and William Blair Analysts Reiterate Buy Rating on Allogene Therapeutics

02:56

Allogene Therapeutics released FY2025 Q3 earnings on November 6 After-Market EST, actual revenue USD 0 (forecast USD 1.82 K), actual EPS USD -0.1864 (forecast USD -0.2224)

00:00

Allogene Therapeutics released FY2025 9 Months Earnings on November 6 After-Market EST, actual revenue USD 0, actual EPS USD -0.7

00:00

Oct30

Allogene Therapeutics to Release FY2025 Q3 Earnings on November 6 After-Market (EST), Forecast Revenue USD 1.82 K, EPS USD -0.2224

00:09

Oct10

Analyst Cheng covers healthcare industry and focuses on specific stocks

09:46

Aug13

Allogene Therapeutics released FY2025 Q2 earnings on August 13 After-Market EST, actual revenue USD 0 (forecast USD 0), actual EPS USD -0.2326 (forecast USD -0.2752)

23:00